Nitrofurantoina Arena

Active Ingredient:: Nitrofurantoin
Origin:: EU

Nitrofurantoina Arena (Nitrofurantoin)

Q: What is Nitrofurantoina Arena used for?

Nitrofurantoina Arena contains nitrofurantoin, an oral urinary antiseptic indicated for the treatment of uncomplicated urinary tract infections, including cystitis, and may be used for short‑term prophylaxis of recurrent infections in selected patients.

Q: How does nitrofurantoin work?

Nitrofurantoin is reduced by bacterial enzymes to reactive metabolites that damage bacterial DNA, ribosomal proteins and cell‑wall synthesis pathways, thereby inhibiting bacterial growth and killing susceptible organisms within the urinary tract.

Q: What is the usual dose of Nitrofurantoina Arena?

The prescribed dose of Nitrofurantoina Arena is determined by the treating clinician based on the patient’s condition, renal function and local prescribing guidelines. Patients should follow the prescriber’s instructions and the product label.

Q: Is Nitrofurantoina Arena safe during pregnancy or breastfeeding?

Nitrofurantoina Arena is classified as Pregnancy Category B, indicating that it is generally considered safe when the potential benefit justifies the potential risk. Limited data are available for breastfeeding; the prescriber should evaluate the risk‑benefit ratio.

Q: How do I order Nitrofurantoina Arena from GNH India?

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Q: How does Nitrofurantoina Arena compare with other urinary antiseptics?

Compared with other agents such as trimethoprim‑sulfamethoxazole, nitrofurantoin offers a narrow spectrum focused on common uropathogens and achieves high urinary concentrations, making it effective for uncomplicated infections while minimizing systemic exposure.

Q: How should Nitrofurantoina Arena be stored and handled?

Store Nitrofurantoina Arena at room temperature, below 25 °C, in its original packaging. Protect the product from moisture, heat and direct sunlight to maintain stability and potency.

Q: How is Nitrofurantoina Arena administered?

Nitrofurantoina Arena is taken orally, usually with a full glass of water. It may be taken with or without food, but patients should avoid taking it together with antacids containing magnesium or aluminum, which can impair absorption.

Q: What are the most serious risks associated with Nitrofurantoina Arena?

Serious risks include pulmonary toxicity (interstitial pneumonitis), severe allergic reactions such as Stevens‑Johnson syndrome, hemolytic anemia in individuals with G6PD deficiency, hepatotoxicity, peripheral neuropathy and acute kidney injury from crystalluria.

Q: Who should not use Nitrofurantoina Arena?

Patients with severe renal impairment (creatinine clearance <60 mL/min), known G6PD deficiency, a history of hypersensitivity to nitrofurantoin, or those taking contraindicated medications such as certain antacids should avoid using Nitrofurantoina Arena.

Nitrofurantoin, the active ingredient in Nitrofurantoina Arena, is a nitrofuran presented as an oral dosage form for oral administration. It is used to treat uncomplicated urinary tract infections, especially cystitis, by targeting bacterial pathogens in the urinary tract of adult patients. The drug is marketed throughout the European Union.

GNH India supplies Nitrofurantoina Arena as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing and regulatory support for global distribution and ensuring product quality throughout the supply chain.

Manufacturer / TM Owner

Arena Group S.A

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Nitrofurantoin is an oral urinary antiseptic that targets bacterial pathogens in the urinary tract and is employed in several clinical scenarios related to urinary infections.
Uncomplicated urinary tract infection: helps eradicate susceptible bacteria, relieving dysuria, frequency and urgency.
Cystitis: treats bladder infection caused by susceptible organisms, leading to symptom resolution.
Prophylaxis of recurrent urinary tract infection: may be prescribed for short‑term prevention in selected patients.
Use in pregnancy (Category B): considered safe for treating urinary infections when benefits outweigh potential risks.

How It Works

Nitrofurantoin is reduced by bacterial flavoproteins to reactive intermediates that damage bacterial DNA, ribosomal proteins and cell wall synthesis enzymes. This inhibition of carbohydrate metabolism and cell wall formation results in bacteriostatic or bactericidal activity, primarily within the urinary tract where the drug is concentrated.

Side Effects

Common Side Effects

Nausea or upset stomach
Loss of appetite
Headache
Diarrhea or loose stools
Darkening of urine
Metallic taste in the mouth

Serious or Rare Side Effects

Pulmonary toxicity (e.g., interstitial pneumonitis)
Severe allergic reactions such as Stevens‑Johnson syndrome
Hemolytic anemia in patients with G6PD deficiency
Hepatotoxicity (liver injury)
Peripheral neuropathy
Acute kidney injury due to crystalluria

Precautions & Warnings

Precautions should be observed when prescribing Nitrofurantoina Arena.
Renal function: assess before initiating, avoid if creatinine clearance <60 mL/min.
Pregnancy: Category B; use only if benefits outweigh risks.
G6PD deficiency: contraindicated due to risk of hemolysis.
Elderly patients: monitor for signs of pulmonary toxicity.
Drug interactions: avoid concomitant use with antacids containing magnesium or aluminum.
Store at room temperature: keep in original container, protect from moisture and light.

Avoid Interactions

Nitrofurantoina Arena may interact with several medicines.

Major Interactions (Avoid)

Antacids containing magnesium or aluminum: reduce nitrofurantoin absorption.
Ciprofloxacin: antagonistic effect reducing antibacterial activity.
Methenamine: decreased efficacy when combined.

Moderate Interactions (Monitor Closely)

Warfarin: may increase INR and bleeding risk.
Diuretics: may increase risk of crystalluria.
Probenecid: may raise nitrofurantoin plasma levels, enhancing toxicity.

Frequently Asked Questions

Nitrofurantoina Arena contains nitrofurantoin, an oral urinary antiseptic indicated for the treatment of uncomplicated urinary tract infections, including cystitis, and may be used for short‑term prophylaxis of recurrent infections in selected patients.

Nitrofurantoin is reduced by bacterial enzymes to reactive metabolites that damage bacterial DNA, ribosomal proteins and cell‑wall synthesis pathways, thereby inhibiting bacterial growth and killing susceptible organisms within the urinary tract.

The prescribed dose of Nitrofurantoina Arena is determined by the treating clinician based on the patient’s condition, renal function and local prescribing guidelines. Patients should follow the prescriber’s instructions and the product label.

Nitrofurantoina Arena is classified as Pregnancy Category B, indicating that it is generally considered safe when the potential benefit justifies the potential risk. Limited data are available for breastfeeding; the prescriber should evaluate the risk‑benefit ratio.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with other agents such as trimethoprim‑sulfamethoxazole, nitrofurantoin offers a narrow spectrum focused on common uropathogens and achieves high urinary concentrations, making it effective for uncomplicated infections while minimizing systemic exposure.

Store Nitrofurantoina Arena at room temperature, below 25 °C, in its original packaging. Protect the product from moisture, heat and direct sunlight to maintain stability and potency.

Nitrofurantoina Arena is taken orally, usually with a full glass of water. It may be taken with or without food, but patients should avoid taking it together with antacids containing magnesium or aluminum, which can impair absorption.

Serious risks include pulmonary toxicity (interstitial pneumonitis), severe allergic reactions such as Stevens‑Johnson syndrome, hemolytic anemia in individuals with G6PD deficiency, hepatotoxicity, peripheral neuropathy and acute kidney injury from crystalluria.

Patients with severe renal impairment (creatinine clearance <60 mL/min), known G6PD deficiency, a history of hypersensitivity to nitrofurantoin, or those taking contraindicated medications such as certain antacids should avoid using Nitrofurantoina Arena.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 27 Sep 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.